Marsden J J, Kember N F, Shaw J E
Br J Cancer Suppl. 1980 Apr;4:88-92.
The DC II mouse chondrosarcoma is a potentially valuable radiobiological tumour system since it has been observed to recover from radiation injury by regrowth from clones that may be counted in histological sections. Unfortunately, the normal growth of this tumour following s.c. implantation in the thigh is irregular both in the time before growth becomes evident and in the rate of growth. The response to radiation is also unreliable since tumours irradiated with the same dose (e.g. 30 Gy) show a range of responses from shrinkage to no detectable change in growth rate. The delay in normal growth can be attributed largely to delays in vascularization while changes in growth rate may be explained by differences in tumour architecture. Radiation response may depend on variations in hypoxic fraction and in relative cellularity. Tumours having the same external dimensions may differ by a factor of 80 in the numbers of tumour cells they contain. This chondrosarcoma may prove a closer model to some human tumours than many transplantable tumours that display regular growth patterns.
DC II型小鼠软骨肉瘤是一种具有潜在价值的放射生物学肿瘤模型,因为据观察,它能从辐射损伤中恢复,通过在组织学切片中可计数的克隆进行再生长。不幸的是,该肿瘤经皮下植入大腿后的正常生长在生长明显之前的时间以及生长速率方面均不规则。对辐射的反应也不可靠,因为用相同剂量(如30 Gy)照射的肿瘤表现出从缩小到生长速率无明显变化的一系列反应。正常生长的延迟很大程度上可归因于血管生成的延迟,而生长速率的变化可能由肿瘤结构的差异来解释。辐射反应可能取决于缺氧分数和相对细胞密度的变化。具有相同外部尺寸的肿瘤,其所含肿瘤细胞数量可能相差80倍。这种软骨肉瘤可能比许多呈现规则生长模式的可移植肿瘤更接近某些人类肿瘤的模型。